| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.25 | 0.0002 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0002 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0004 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.24 | 0.0005 |